Building on our strong growth in the first half of the year and continued underlying demand for our medicines we are upgrading our FY 2024 guidance for both Total Revenue and Core EPS.
Pascal Soriot, Executive Director and Chief Executive Officer, AstraZeneca
澳门葡京赌博游戏有
189
projects in our pipeline
Corporate Press Release